@sofasphere21
-
Ziegler Olsson posted an update 17 days ago
generic competition related to introduction of a new version of branded glatiramer acetate was associated with $4.3 billion to $6.5 billion in excess spending. Extended market exclusivity from introducing a new version of an existing brand-name drug can yield manufacturer returns out of proportion to the level of investment or risk involved; more…[Read more]
-
Ziegler Olsson posted an update 17 days ago
73-32.95)]. No effect of hydromorphone on the incidence of PASC was identified . Longer procedures (>2 hours) were identified as an independent risk factor for PASC .
No association between hydromorphone and an increase in the incidence of PASC was identified. Anesthesia for colic surgery and duration of anesthesia were associated with an…[Read more]
-
Ziegler Olsson became a registered member 17 days ago